Clinical Intelligence

Predict Drug Approvals
Before the Market

Evidence-based probability scores synthesized from ClinicalTrials.gov, FDA adverse events, and SEC regulatory filings. Know the odds before anyone else.

Popular Queries
3
Data Sources
24h
Update Cycle
FDA
FAERS Data
SEC
NLP Analysis

How It Works

Our engine aggregates three independent data streams to compute probabilistic FDA approval scores.

Clinical Trials

Real-time ingestion from ClinicalTrials.gov. Track phase transitions, enrollment, endpoints, and status changes for any drug candidate.

Phase 1: 8% → Phase 3: 65% baseline

Safety Signals

OpenFDA FAERS adverse event analysis. Compare drug safety profiles against mechanism class baselines to detect elevated risks.

GLP-1 class baseline comparison

Regulatory Sentiment

NLP analysis of SEC 10-K, 10-Q, 8-K filings. Extract FDA meeting outcomes, risk factor changes, and regulatory language shifts.

Sentiment quartile scoring